| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2023-08-01 08:00:57 UTC |
|---|
| Updated at | 2025-02-11 15:45:12 UTC |
|---|
| NP-MRD ID | NP0331742 |
|---|
| Natural Product DOI | https://doi.org/10.57994/0776 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Tenaciside P |
|---|
| Description | Tenaciside P belongs to the class of organic compounds known as vitamin d and derivatives. Vitamin D and derivatives are compounds containing a secosteroid backbone, usually secoergostane or secocholestane. Tenaciside P was first documented in 2023 (PMID: 37451564). Based on a literature review very few articles have been published on Tenaciside P. |
|---|
| Structure | [H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@@H](OC(C)=O)[C@]3(C)[C@H](CC[C@@]33O[C@@]13CC=C1C[C@H](CC[C@]21C)O[C@H]1C[C@@H](OC)[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]2O)[C@@H](C)O1)C(C)=O InChI=1S/C44H60O14/c1-22(45)29-16-19-44-42(29,6)38(54-25(4)46)36(56-39(49)26-12-10-9-11-13-26)37-41(5)17-15-28(20-27(41)14-18-43(37,44)58-44)55-31-21-30(50-7)34(24(3)52-31)57-40-33(48)35(51-8)32(47)23(2)53-40/h9-14,23-24,28-38,40,47-48H,15-21H2,1-8H3/t23-,24-,28+,29-,30-,31+,32-,33-,34-,35-,36+,37-,38-,40+,41+,42+,43+,44-/m1/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C44H60O14 |
|---|
| Average Mass | 812.9500 Da |
|---|
| Monoisotopic Mass | 812.39831 Da |
|---|
| IUPAC Name | (1S,3R,6S,7S,8S,9S,10S,11R,14S)-6-acetyl-8-(acetyloxy)-14-{[(2R,4R,5R,6R)-5-{[(2S,3R,4R,5R,6R)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-7,11-dimethyl-2-oxapentacyclo[8.8.0.0^{1,3}.0^{3,7}.0^{11,16}]octadec-16-en-9-yl benzoate |
|---|
| Traditional Name | (1S,3R,6S,7S,8S,9S,10S,11R,14S)-6-acetyl-8-(acetyloxy)-14-{[(2R,4R,5R,6R)-5-{[(2S,3R,4R,5R,6R)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-7,11-dimethyl-2-oxapentacyclo[8.8.0.0^{1,3}.0^{3,7}.0^{11,16}]octadec-16-en-9-yl benzoate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@@H](OC(C)=O)[C@]3(C)[C@H](CC[C@@]33O[C@@]13CC=C1C[C@H](CC[C@]21C)O[C@H]1C[C@@H](OC)[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]2O)[C@@H](C)O1)C(C)=O |
|---|
| InChI Identifier | InChI=1S/C44H60O14/c1-22(45)29-16-19-44-42(29,6)38(54-25(4)46)36(56-39(49)26-12-10-9-11-13-26)37-41(5)17-15-28(20-27(41)14-18-43(37,44)58-44)55-31-21-30(50-7)34(24(3)52-31)57-40-33(48)35(51-8)32(47)23(2)53-40/h9-14,23-24,28-38,40,47-48H,15-21H2,1-8H3/t23-,24-,28+,29-,30-,31+,32-,33-,34-,35-,36+,37-,38-,40+,41+,42+,43+,44-/m1/s1 |
|---|
| InChI Key | DTSJOQCNIHMNLN-IGRAGCOISA-N |
|---|
| Experimental Spectra |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D_DEPT NMR | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | xht8710@163.com | Not Available | Not Available | 2024-05-09 | View Spectrum | | NOESY NMR | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | xht8710@163.com | Not Available | Not Available | 2023-08-01 | View Spectrum | | HMBC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | xht8710@163.com | Not Available | Not Available | 2023-08-01 | View Spectrum | | COSY NMR | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | xht8710@163.com | Not Available | Not Available | 2023-08-01 | View Spectrum | | HSQC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | xht8710@163.com | Not Available | Not Available | 2023-08-01 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | xht8710@163.com | Not Available | Not Available | 2023-08-01 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | xht8710@163.com | Not Available | Not Available | 2023-08-01 | View Spectrum |
| | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| | Chemical Shift Submissions |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 600, CD3OD, simulated) | Not Available | Not Available | Not Available | 2024-05-09 | View Spectrum |
| | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | This compound belongs to the class of organic compounds known as vitamin d and derivatives. These are compounds containing a secosteroid backbone, usually secoergostane or secocholestane. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Vitamin D and derivatives |
|---|
| Direct Parent | Vitamin D and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Triterpenoid
- Steroid ester
- Fatty acyl glycoside of mono- or disaccharide
- Fatty acyl glycoside
- Fatty alcohol ester
- Alkyl glycoside
- Benzoate ester
- Benzoic acid or derivatives
- Benzoyl
- Oxepane
- Fatty acid ester
- Fatty acyl
- Benzenoid
- Oxane
- Monosaccharide
- Dicarboxylic acid or derivatives
- Monocyclic benzene moiety
- Alpha,beta-unsaturated carboxylic ester
- Enoate ester
- Secondary alcohol
- Ketone
- Carboxylic acid ester
- Oxacycle
- Organoheterocyclic compound
- Ether
- Oxirane
- Dialkyl ether
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Alcohol
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|